| Chapter 1 - Gastro-intestinal system |
| 1.1 - Chronic bowel disorders |
| 1.2 - Constipation and bowel cleansing |
| 1.3 - Diarrhoea |
| 1.6 - Gastric acid disorders and ulceration |
| 1.7 - Gastro-intestinal smooth muscle spasm |
| 1.9 – Obesity |
| 1.10 – Rectal and anal disorders |
| Chapter 2 - Cardiovascular System |
| 2.1 Positive inotropic drugs |
| 2.2 Diuretics |
| 2.3 Anti-arrhythmic drugs |
| 2.4 Beta-adrenoreceptor blocking drugs |
| 2.5 Drugs affecting the renin-angiotensin system |
| 2.5 Summary of Antihypertensive Drug Treatment |
| 2.5 Care Pathway for Hypertension |
| 2.5 Prescribing Guidelines for Heart Failure Guidance |
| 2.6 Nitrates, CCBs and potassium channel activators |
| 2.6 Primary Care Guidelines for drug treatment of Chronic Stable Angina Pectoris |
| 2.6.3 Other antianginal drugs |
| 2.6.4 Peripheral vasodilators and related drugs |
| 2.8 Anticoagulant drugs |
| 2.8.2 Oral anticoagulants |
| 2.8.2 Drug Interactions for Apixaban, Dabigatran, Edoxaban and Rivaroxaban |
| 2.8.2 Decision aid for patients requiring stroke prevention in AF |
| 2.8.2 Reducing the risk of stroke in Atrial Fibrillation - NICE CG180 (including decision aid) |
| 2.8.2 NOAC Implementation priorities |
| 2.9 Antiplatelet drugs |
| 2.12 Lipid regulation |
| 2.12 Lipid regulating drugs |
| Chapter 3 - Respiratory System |
| 3 Introduction |
|
| Asthma Inhaler Pathways |
| Asthma Step-down Guides |
| Summary of recently introduced inhalers and their equivalents |
| 3.1 Bronchodilators |
| 3.2 Corticosteroids |
| 3.3.2 Leukotriene receptor antagonists |
| Guidance for managing COPD |
| 3.7 - Mucolytics |
| Chapter 4 - Central Nervous System |
| 4.1 - Hypnotics and anxiolytics |
| 4.2 - Drugs used in psychoses and related disorders |
| 4.2.3 - Antimanic drugs |
| 4.3 - Antidepressants |
| 4.5 - CNS stimulants and drugs for ADHD |
| 4.5.1 - Drugs used in the treatment of obesity |
| 4.7 - Analgesics |
| 4.7.3 - Neuropathic pain |
| 4.7.4 - Antimigraine drugs |
| 4.8.1 - Epilepsy |
| 4.8.2 - Drugs used in status epilepticus |
| 4.10 - Drugs used in substance dependence |
| 4.11 - Drugs for dementia |
| Chapter 5 - Infections |
| Chapter 6 - Endocrine System |
| 6.1 - Drugs used in diabetes |
| 6.1.1 - Insulins |
| 6.1.2 - Drugs used in diabetes |
| 6.1 - Guidance on the use of Blood Glucose Testing Strips |
| 6.2 - Thyroid and anti-thyroid drugs |
| 6.3 - Corticosteriods |
| 6.4.1 - Hormone Replacement Therapy |
| 6.4.2 - Male sex hormones and antagonists |
| 6.5.2 - Posterior pituitary hormones and antagonists |
| 6.2 - Bone metabolism disorders |
| Chapter 7 – Genito-urinary system |
| 7.1 – Bladder and urinary disorders |
| 7.3 - Contraception |
| 7.4 – Erectile and ejaculatory conditions |
| 7.7 – Vaginal and vulval conditions |
| Chapter 8 - Immune system and malignant disease |
| 8.4 - Hormone responsive malignancy |
| Chapter 9 - Nutrition and Blood |
| 9.1 - Anaemias |
| 9.2 - Fluid and Electrolyte imbalances |
| 9.3 - Vitamin deficiency |
| Chapter 10 - Musculoskeletal system |
| 10.1 – Arthritis |
| 10.2 – Hyperuricaemia and gout |
| Chapter 11 – Eye |
| 11.1 - Allergic and inflammatory eye conditions |
| 11.2 – Dry eye conditions |
| 11.3 – Eye infections |
| 11.4 – Eye procedures |
| 11.5 – Glaucoma and ocular hypertension |
| Chapter 12 – Drugs acting on the Ear |
| 12.1 – Drugs acting on the Nose |
| 12.2 – Nasal Allergy |
| 12.3 – Drugs acting on the Oropharynx |
| Chapter 13 – Skin |
| 13.1 – Dry and scaling skin disorders |
| 13.2 – Infections of the skin |
| 13.3 – Inflammatory skin conditions |
| 13.5 - Pruritus |
| 13.6 – Rosacea and acne |
| 13.10 – Sun protection and photodamage |
| Chapter 15 & 16 - Anaesthesia and Emergency treatment of poisoning |
